Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00897091 · ClinicalTrials.gov registry record
S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and Fluorouracil
A clinical trial, sponsored by SWOG Cancer Research Network.
- Completed
- Registry status
- 750
- Enrollment target
NCT00897091: Completed study, sponsored by SWOG Cancer Research Network.
NCT00897091 is a clinical trial that has completed, run by SWOG Cancer Research Network. The registered enrollment target is 750 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00897091 has completed, sponsored by SWOG Cancer Research Network.
- COMPLETED
- Registry status
- 750 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This laboratory study is looking at biomarkers in predicting outcome in postmenopausal women with hormone receptor-positive, node-positive breast cancer treated with tamoxifen with or without cyclophosphamide, doxorubicin, and fluorouracil.
Interventions
- GENETIC microarray analysis
- OTHER diagnostic laboratory biomarker analysis
- GENETIC reverse transcriptase-polymerase chain reaction
- GENETIC comparative genomic hybridization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2006-07 |
| Est. Completion | 2007-10 |
What the finished NCT00897091 record still lists
NCT00897091 is an observational study that tracks outcomes without assigning an intervention. The registered 750 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 4 interventions - of which microarray analysis is the first listed.
NCT00897091 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00897091 about?
NCT00897091 is a clinical study titled "S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and Fluorouracil". RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This laboratory study is l...
What is the current status of trial NCT00897091?
This trial is currently completed. The enrollment target is 750 participants. The study started on 2006-07. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00897091?
The interventions under investigation include: microarray analysis (GENETIC), diagnostic laboratory biomarker analysis (OTHER), reverse transcriptase-polymerase chain reaction (GENETIC), comparative genomic hybridization (GENETIC).
Who is sponsoring clinical trial NCT00897091?
This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02048332 · 750 participants · Phase 1
Donor-Derived Viral Specific T-cells (VSTs)
- NCT02087852 · 750 participants
Kidney Cancer DNA Registry
- NCT02532452 · 750 participants · Phase 2
Third Party Viral Specific T-cells (VSTs)
- NCT03126916 · 750 participants · Phase 3
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia